Physician

Veronica T. Dugan, M.D.

According to 2025 Medicare claims, Veronica Dugan, M.D. (NPI: 1245292515) practices gastroenterology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC (NPI: 1295428415; TIN: 752005254) and primary practice location at 70461-5423. Dugan is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Dugan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 421 traditional Medicare patients, billed 9,181 HCPCS/CPT codes, and received $234,723 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,934 prescription claims across 628 beneficiaries totaling $1,930,533 in drug costs, led by Sucraid (Sacrosidase). 2021 DME data shows 79 claims. Open Payments data shows 187 records totaling $2,778. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $114,704 and ending at $234,723. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	484	1,237	$114,704
2016	380	964	$94,795
2017	353	937	$81,905
2018	352	1,542	$110,040
2019	383	1,851	$133,817
2020	359	1,475	$99,147
2021	317	1,552	$107,608
2022	320	1,208	$82,886
2023	349	3,331	$142,135
2024	421	9,181	$234,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	2,987	$2,500,140
2016	554	2,937	$1,110,767
2017	550	2,914	$1,023,946
2018	489	2,497	$981,551
2019	492	2,546	$930,089
2020	471	2,621	$1,598,239
2021	480	2,665	$1,607,456
2022	488	2,389	$1,374,785
2023	585	2,762	$1,932,042
2024	628	2,934	$1,930,533

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	163	$82,021
2019	N/R	206	$106,095
2020	N/R	56	$29,697
2021	N/R	79	$35,142
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	87	88	$172
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	71	74	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	246	$85
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	114	120	$84
43450	Dilation of esophagus	70	74	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucraid	Sacrosidase	67	2,010	$859,837
Linzess	Linaclotide	217	9,330	$164,086
Xifaxan	Rifaximin	46	1,162	$142,203
Creon	Lipase/Protease/Amylase	17	447	$41,030
Relistor	Methylnaltrexone Bromide	30	414	$31,215

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	186	$2,778	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$9,501	GastroGPO, LLC

Explore More Providers

FAQ

What Medicare data is available for Veronica T. Dugan, M.D.?

Tedicare shows public-source Medicare data for Veronica T. Dugan, M.D. (NPI 1245292515), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Veronica T. Dugan, M.D. have ACO affiliation data?

Veronica T. Dugan, M.D. is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to Veronica T. Dugan, M.D.?

Veronica T. Dugan, M.D. is linked to TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC (billing NPI 1295428415) in the available physician profile data.

Does Veronica T. Dugan, M.D. have Open Payments data?

Veronica T. Dugan, M.D. has 187 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.